版本:
中国

BRIEF-Fate Therapeutics announces FDA clearance of investigational new drug application for FATE-NK100

May 10 Fate Therapeutics Inc

* Fate Therapeutics announces FDA clearance of investigational new drug application for FATE-NK100 in advanced solid tumors Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐